Marc Beer, businessman and entrepreneur, OS the co-foumder of Renovia, Inc
, and currently the CEO ( Chief Executive Officer) and chairman of the company. The entity is a medical technology company based on Boston, Massachusetts that is developing diagnostic and therapeutic devices that are used to treat pelvic floor disorders such as urinary incontinence. The company recently completed a round of funding and closed that round with a total of $42 million. Of that, $10 million was from Venture capital and $32 million was from Series B funding. The first product Renovia developed was a product called Leva which received FDA (Food and Drug Administration) approval on April,of 2018.
An early investor in Renovia was the Longwood Fund, an investing firm that focuses on healthcare. The Series B funding round was led by Perceptive Advisors and Ascenion Ventures. The funds from the capital raising effort will support the development and testing of four additional diagnostic and therapeutic products. Included in the effort will be an enhancement of the Leva product. Renovia is excited to have the support of those interested on the investment of such healthcare aspects. The products will ultimately benefit millions of women who differ from pelvic floor disorders. The products will ultimately benefit the millipn S of women who suffer from pelvic floor disorders. The combination of state of the art technology and funding will allow customers access to data and information that will allow them to make better informed decisions and add to the quality of life of many. The overall upshot is to help lower the cost of certain aspects of healthcare for users.
Marc Beer had more than 25 years of experience in the development and commercial marketing of pharmaceuticals, biotechnology and medical devices. In April of 2000, Beets was the founder and CEO of a biotechnogy company that focused on the collection and preservation process of umbilical cord blood stem cells. During his tenure at ViaCell, his leadership brought the company from start-up to a wry robust commercial enterprise. The company grew from a handful of employees to more than 300 and in 2007 the company was acquired by PerkinElmer.
Mr. b.Beets also served as a board of director member of Erytech Pharma, which is a biopharmaceutical company. Early in his career, Beers handled employment opportunities and challenges with a company called Genzyme. He was the Vice President of Global Marketing and he was responsible for launching several products that addressed several rate doase issues globally. He also served on the Governing Board of the Biotechnology Industry Organization Emerging Companies, as well as the Commonwealth of Massachusetts of Mass Life Science Board.
Marc Beets earned a Bachelor of Science degree (BS) from Miami University. He is also a mbet of the Miami University Business Advisory Council and a former member of the Notre Dame Graduate Studies Research and Advisory Council. Learn more : https://renoviainc.com/leadership/